How is the Novavax, Inc. today?

The Novavax, Inc. today is trading in the down by -1.98% at 5.95.

What is Novavax, Inc. Annual Revenue?

Novavax, Inc. Annual Revenue rose 22.61%, in the last year to $682.16 M. Its sector's average revenue growth for the last fiscal year was 7.53%.

What is Novavax, Inc. Annual Net Profit?

Novavax, Inc. Annual Net Profit rose 65.6% in the last year to $187.5 M. Its sector's average net profit growth for the last fiscal year was -31.39%.

What is Novavax, Inc. Price to Earning Ratio?

Novavax, Inc. Price to Earning Ratio is -5.14, which is negative.

What is Novavax, Inc. Stock Price?

Novavax, Inc. Stock Price rose 29.07% and outperformed its sector by 23.97% in the past year.

What is Novavax, Inc. Quarterly Revenue?

Novavax, Inc. Quarterly Revenue fell 65.15% YoY to $88.31 M. Its sector's average revenue growth YoY for the quarter was 5.23%.

What is Novavax, Inc. Quarterly Net profit?

Novavax, Inc. Quarterly Net profit rose 54.58% YoY to $81.03 M. Its sector's average net profit growth YoY for the quarter was -29.17%.

What is Novavax, Inc. Mutual Fund Holding?

Novavax, Inc. Mutual Fund Holding decreased by 1.11% in the last quarter to 30.73.

What is Novavax, Inc. Promoter Share Holding?

Novavax, Inc. Promoter Share Holding increased by 0.31% in the most recent quarter to 1.58%.

What is Novavax, Inc. Interest Coverage Ratio?

Novavax, Inc. Interest Coverage Ratio is -7.8, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Novavax, Inc. Institutional Holding?

Novavax, Inc. Institutional Holding decreased by 0.35% in the last quarter to 63.56.

Novavax, Inc. XNAS: NVAX

Novavax, Inc. Live Share Price Today, Share Analysis and Chart

Name: Novavax, Inc.: Is Infosys Ltd. worth buying?
Item: Novavax, Inc.
Rating: 0.91325
Author: Trendlyne DVM scores

about

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish su...

5.95 -0.12 (-1.98%)

75.06% Fall from 52W High

4.5M XNAS Volume

XNAS 07 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Novavax, Inc. is on 09 May 2025 for the purpose of Novavax Inc First Quarter Earnings Results for 2025 See details

Not Eligible

-

Expensive Valuation

13.0 / 100

Technically Bearish

23.5 / 100

16

1Yr Price target upside is 162%

7 analysts

Novavax, Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Novavax, Inc. FAQ

How is Novavax, Inc. today?

Novavax, Inc. today is trading in the red, and is down by -1.98% at 5.95.

How has Novavax, Inc. performed historically?

Novavax, Inc. is currently trading down -1.98% on an intraday basis. In the past week the stock fell -10.79%. stock has been down -26.81% in the past quarter and rose 29.07% in the past year. You can view this in the overview section.